Browsing Tag
CT1812
1 post
Zervimesine development highlights regulatory complexity in dementia with Lewy bodies
Zervimesine moves closer to Phase 2b as Cognition Therapeutics engages FDA. Read how regulatory complexity is shaping dementia drug development.